The development and psychometric validation of the central sensitization inventory
- PMID: 21951710
- PMCID: PMC3248986
- DOI: 10.1111/j.1533-2500.2011.00493.x
The development and psychometric validation of the central sensitization inventory
Abstract
Central sensitization (CS) has been proposed as a common pathophysiological mechanism to explain related syndromes for which no specific organic cause can be found. The term "central sensitivity syndrome (CSS)" has been proposed to describe these poorly understood disorders related to CS. The goal of this investigation was to develop the Central Sensitization Inventory (CSI), which identifies key symptoms associated with CSSs and quantifies the degree of these symptoms. The utility of the CSI, to differentiate among different types of chronic pain patients who presumably have different levels of CS impairment, was then evaluated. Study 1 demonstrated strong psychometric properties (test-retest reliability = 0.817; Cronbach's alpha = 0.879) of the CSI in a cohort of normative subjects. A factor analysis (including both normative and chronic pain subjects) yielded 4 major factors (all related to somatic and emotional symptoms), accounting for 53.4% of the variance in the dataset. In Study 2, the CSI was administered to 4 groups: fibromyalgia (FM); chronic widespread pain without FM; work-related regional chronic low back pain (CLBP); and normative control group. Analyses revealed that the patients with FM reported the highest CSI scores and the normative population the lowest (P < 0.05). Analyses also demonstrated that the prevalence of previously diagnosed CSSs and related disorders was highest in the FM group and lowest in the normative group (P < 0.001). Taken together, these 2 studies demonstrate the psychometric strength, clinical utility, and the initial construct validity of the CSI in evaluating CS-related clinical symptoms in chronic pain populations.
Published 2011. No claim to original US government works. Pain Practice © 2011 World Institute of Pain.
Figures
Similar articles
-
The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample.J Pain. 2013 May;14(5):438-45. doi: 10.1016/j.jpain.2012.11.012. Epub 2013 Mar 13. J Pain. 2013. PMID: 23490634 Free PMC article.
-
Cross-Cultural Adaptation and Psychometric Validation of the Serbian Version of the Central Sensitization Inventory.Pain Pract. 2018 Apr;18(4):463-472. doi: 10.1111/papr.12618. Epub 2017 Nov 20. Pain Pract. 2018. PMID: 28777895
-
Cross-cultural Adaptation and Psychometric Properties of the Greek Version of the Central Sensitization Inventory.Pain Pract. 2020 Feb;20(2):188-196. doi: 10.1111/papr.12843. Epub 2020 Jan 6. Pain Pract. 2020. PMID: 31605651
-
Central sensitization in chronic low back pain: A narrative review.J Back Musculoskelet Rehabil. 2016 Nov 21;29(4):625-633. doi: 10.3233/BMR-160685. J Back Musculoskelet Rehabil. 2016. PMID: 27062464 Review.
-
Questionnaires for the Assessment of Central Sensitization in Endometriosis: What Is the Available Evidence? A Systematic Review with a Narrative Synthesis.Reprod Sci. 2024 Mar;31(3):633-644. doi: 10.1007/s43032-023-01343-4. Epub 2023 Sep 26. Reprod Sci. 2024. PMID: 37751146 Free PMC article. Review.
Cited by
-
Deciphering nociplastic pain: clinical features, risk factors and potential mechanisms.Nat Rev Neurol. 2024 Jun;20(6):347-363. doi: 10.1038/s41582-024-00966-8. Epub 2024 May 16. Nat Rev Neurol. 2024. PMID: 38755449 Review.
-
Cross-cultural adaption, validity, and reliability of the Japanese version of the Central Aspects of Pain in the Knee (CAP-Knee-J) questionnaire in patients with knee pain: a validation study.BMC Musculoskelet Disord. 2024 May 9;25(1):365. doi: 10.1186/s12891-024-07471-5. BMC Musculoskelet Disord. 2024. PMID: 38730443 Free PMC article.
-
Central sensitization significantly deteriorates functionality and the interpretation of self-reported disease activity in primary Sjögren's syndrome.Clin Rheumatol. 2024 Jun;43(6):1949-1958. doi: 10.1007/s10067-024-06981-w. Epub 2024 May 1. Clin Rheumatol. 2024. PMID: 38691249
-
Counting your chickens before they hatch: improvements in an untreated chronic pain population, beyond regression to the mean and the placebo effect.Pain Rep. 2024 Apr 26;9(3):e1157. doi: 10.1097/PR9.0000000000001157. eCollection 2024 Jun. Pain Rep. 2024. PMID: 38689593 Free PMC article.
-
Injuries and Persistent Pain in Elite Adolescent Archery Athletes: A Cross-Sectional Epidemiological Study.Sports (Basel). 2024 Apr 2;12(4):101. doi: 10.3390/sports12040101. Sports (Basel). 2024. PMID: 38668569 Free PMC article.
References
-
- Reif W, Hessel A, Braehler E. Somatization symptoms and hypochondriacal features in the general population. Psychosomatic Medicine. 2001;63:595–602. - PubMed
-
- Lydiard RB, Fossey MD, Marsh W, Ballenger JC. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. Psychosomatics. 1993;34(3):229–234. - PubMed
-
- Ahles TA, Khan SA, Yunus MB, Spiegel DA, Masi AT. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: A blind comparison of DSM-III diagnoses. American Journal of Psychiatry. 1991;148(12):1721–1726. - PubMed
-
- Kroenke K, Mangelsdorff A. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Annual Journal of Medicine. 1989;86(3):262–266. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical